PowerPoint Presentation


www.admedus.com


ADMEDUS INVESTOR PRESENTATION October, 2015


DISCLAIMER


This presentation is the property of Admedus Ltd ('Admedus'). This presentation is not and does not constitute an offer, invitation or recommendation to subscribe for, or purchase any security and neither this presentation nor anything contained in it shall form the basis of any contract or commitment.

This presentation does not constitute an offer or invitation in any jurisdiction anywhere, or to any person to whom, such an offer would be unlawful. This presentation is not intended as an offer, invitation, solicitation or recommendation with respect to the purchase or sale of any security in the United States or to any person to whom it is unlawful to make such an offer or solicitation. The securities in the offering have not been, and will not be registered under the US Securities Act.

Reliance should not be placed on the information or opinions contained in this presentation. This presentation does not take into consideration the investment objectives, financial situation or particular needs of any particular investor. Any decision to purchase or subscribe for securities in Admedus must be made solely on the basis of the information contained in the public domain and if necessary after seeking appropriate financial advice.

No representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information, opinions and conclusions contained in this presentation. To the maximum extent permitted by law, Admedus and its affiliates and related bodies corporate, and their respective officers, directors, employees and agents disclaim any liability (including, without limitation, any liabilities arising from fault or negligence) for any loss arising from any use of this presentation (or its content) or otherwise arising in connection with it.

Admedus' forward-looking statements, intentions, forecasts, prospects, returns, expectations, statements in relation to future matters or other forward looking statement contained in this presentation may involve significant elements of subjective judgement and assumptions as to future events which may or may not be correct. There are usually differences between forecast and actual results because events and actual circumstances frequently do not occur as forecast and these differences may be material. They are based on a number of estimates, assumptions that are subject to business, scientific, economic and competitive uncertainties and contingencies, with respect to future business decisions, which are subject to change and, in many cases, are outside the control of Admedus and its directors. Neither Admedus nor its directors give any assurance that the forecast performance in the forecasts or any forward-looking statement contained in this presentation will be achieved.


1www.admedus.com


www.admedus.com


ADMEDUS PRESENTATION OVERVIEW


  • Admedus Overview and 4C Highlights

  • ADAPT® Regenerative Tissue

  • Immunotherapies

  • Company Milestones and News Flow

  • Q & A


CORPORATE OVERVIEW


  • Fully integrated Specialist Healthcare Company with global footprint

  • Leveraging two proprietary and differentiated platform technologies

    • ADAPT® - tissue engineering for regenerative medicine

    • Therapeutic vaccines and immunotherapies for infectious disease and oncology

  • Significant value and springboard for growth built over the past 2 years

    • Rollout of lead ADAPT product, CardioCel® ongoing-used in 110 centers globally inc US & EU

      • Initially targeting the significant cardiovascular repair market

    • Cardiocel launch de-risks underlying ADAPT platform

      • Now Expanding Regenerative pipeline into additional targets

    • Key value inflection points for immunotherapy programs in 2015 / 2016

  • Strong IP position across both platforms underpins broad pipeline

  • Experienced management team


3www.admedus.com

distributed by